Plavix Patent Trial Delayed

Law360, New York (July 22, 2004, 12:00 AM EDT) -- A trial over patent rights to Sanofi-Synthélabo’s best-selling blood-thinning drug Plavix has been delayed until next year, leaving a shadow over the French pharmaceutical company.

A change of judge in the Plavix lawsuit, with U.S. District Judge Sidney Stein taking over earlier this year, has delayed the trial by "three to six months,” Hanspeter Spek, Sanofi's head of pharmaceutical operations, told a press conference.

He said a verdict was not expected "before the first or second quarters of 2005.”

The patent to the drug, Sanofi’s best-selling...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.